![]() |
市场调查报告书
商品编码
1954624
测高仪和地形测量系统市场规模、占有率、成长及全球产业分析:依类型、应用和地区划分的洞察与预测(2026-2034 年)Aberrometer and Topography Systems Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025 年全球测高仪和地形测量系统市场规模为 5.0124 亿美元,预计 2026 年将成长至 5.2838 亿美元,到 2034 年将达到 8.3673 亿美元。预测期内的复合年增长率预计为 6.61%。预计到2025年,北美将以17.59%的市场占有率引领市场,这主要归功于接受眼科手术的患者人数不断增加以及先进眼科诊断技术的快速普及。
视差计和角膜地形图系统对现代眼科医学至关重要。视差计测量眼球内的光学像差,评估光线通过角膜和水晶体折射的缺陷,进而影响视觉品质。角膜地形图可提供角膜曲率和形状的详细图谱,有助于诊断和治疗各种眼部疾病。散光、远视和白内障等视力障碍的日益普遍推动了对这些先进诊断解决方案的需求。根据美国国家生物技术资讯中心(NCBI)统计,全球40%的成年人患有散光,凸显了对精准眼科诊断日益增长的需求。
市场动态
驱动因素:生活方式的改变、糖尿病以及因老化导致的眼科疾病盛行率上升是主要的成长驱动因素。预计到2050年,近视将影响全球50%的人口,凸显了使用波前像差测量设备和地形图系统进行早期诊断的重要性。各国政府和医疗机构对预防性眼科保健的重视也进一步推动了对诊断设备的需求。
限制因素:先进设备的高昂成本(例如,预计到2025年,Nidek OPD-Scan III波前像差仪的价格将达到约15,000美元)限制了其在发展中地区的普及。此外,中低收入国家对定期眼科检查的认知不足也阻碍了市场渗透。世界卫生组织的数据显示,全球有22亿人患有视力障碍,其中10亿人本可预防,反映出人们对视力障碍的认知存在差距。
机会:主要参与者之间的策略联盟和收购正在创造市场扩张的机会。例如,卡尔蔡司医疗技术股份公司于2024年4月收购了D.O.R.C.,从而增强了其眼科解决方案组合。合作关係将加速下一代诊断工具的开发,并促进产品创新和新产品上市。
挑战:训练有素的眼科专业人员短缺可能会阻碍市场成长。截至2024年,美国祇有不到6万名眼科技术人员为超过1.9万名眼科医生提供支持,这可能会限制患者获得先进诊断服务的机会。
市场区隔
依类型划分:市场区隔分为像差仪和地形图系统。哈特曼-夏克法和光线追踪等技术创新使像差仪产业占了领先地位。例如,Tracey Technologies 于 2023 年 2 月推出了 iTrace Prime,增强了其像差仪和角膜地形测量功能。包括 Placido 圆盘法和 Schein-Frug 法在内的角膜地形图系统也在不断扩展,透过整合人工智慧和物联网技术来提高诊断准确性。
依适应症划分:远视、近视和散光是该市场的主要适应症。由于远视在成人(30.9%)和儿童(4.6%)的高发病率,预计远视将占较大的市场占有率。近视的增加是由于萤幕使用时间和人口老化,而散光则受益于能够提供精确角膜图的先进角膜地形图系统,例如 Cassini 角膜地形图仪。
依最终用户划分:医院由于其手术量大且拥有先进的设备,因此处于领先地位。同时,由于诊断解决方案的日益普及,眼科诊所预计将以最高的复合年增长率成长。远距医疗和学术诊所正透过远距验光服务的扩展(例如 Visionix 和 20/20NOW 等,预计在 2023 年)成为重要的成长贡献者。
技术创新正在改变市场格局,包括动态波前像差测量、多模态地形图以及用于远距眼科会诊的便携式设备。人工智慧和物联网的融合正在提升诊断准确性、工作流程效率和个人化患者护理水准。
新冠疫情的影响
由于病患就诊量减少和供应链中断,疫情导致需求暂时下降。卡尔蔡司医疗技术股份公司报告称,2020年销售额下降了7%。自2021年以来,随着患者就诊量的增加,市场呈现復苏趋势。
The global aberrometer & topography systems market was valued at USD 501.24 million in 2025 and is projected to grow to USD 528.38 million in 2026, reaching USD 836.73 million by 2034, registering a CAGR of 6.61% during the forecast period. North America led the market in 2025 with a 17.59% share, primarily due to the rising number of individuals undergoing eye surgeries and the rapid adoption of advanced ophthalmic diagnostic technologies.
Aberrometers and corneal topography systems are crucial in modern ophthalmology. An aberrometer measures optical aberrations in the eye, assessing imperfections in light refraction through the cornea and lens, affecting vision quality. Corneal topography provides detailed mapping of corneal curvature and shape, aiding in the diagnosis and management of various ocular conditions. The rising prevalence of visual impairments such as astigmatism, hyperopia, and cataracts has spurred demand for these advanced diagnostic solutions. According to NCBI, astigmatism affects 40% of adults globally, emphasizing the growing need for accurate eye diagnostics.
Market Dynamics
Drivers: The increasing incidence of ophthalmic diseases, driven by lifestyle changes, diabetes, and an aging population, is a major growth driver. Myopia is projected to affect 50% of the global population by 2050, highlighting the importance of early diagnosis using aberrometers and topography systems. Governments and healthcare providers are prioritizing preventive eye care, further boosting demand for diagnostic devices.
Restraints: The high cost of advanced devices, such as the Nidek OPD-Scan III Wavefront Aberrometer priced around USD 15,000 in 2025, limits adoption in developing regions. Additionally, limited awareness regarding routine eye exams in low- and middle-income countries reduces market penetration. WHO data indicates 2.2 billion people worldwide suffer from vision impairment, with 1 billion cases preventable, reflecting the awareness gap.
Opportunities: Strategic alliances and acquisitions among key players are creating opportunities for market expansion. For instance, Carl Zeiss Meditech AG acquired D.O.R.C. in April 2024, enhancing its portfolio of ophthalmic solutions. Partnerships facilitate the development of next-generation diagnostic tools, fueling product innovation and new launches.
Challenges: The shortage of trained ophthalmic professionals could hinder market growth. In the U.S., there were fewer than 60,000 ophthalmic technicians supporting over 19,000 ophthalmologists as of 2024, potentially limiting patient access to advanced diagnostic services.
Market Segmentation
By Type: The market is segmented into aberrometers and topography systems. The aberrometer segment dominates due to innovations like Hartmann-Shack and Ray-Tracing techniques. For example, Tracey Technologies launched iTrace Prime in February 2023, enhancing aberrometer and topographer functionalities. Topography systems, including Placido disc and Scheimpflug imaging, are also expanding with AI and IoT integration for improved diagnostics.
By Indication: Hyperopia, myopia, astigmatism, and others form the market indications. Hyperopia is projected to hold a significant share due to its prevalence in adults (30.9%) and children (4.6%). Myopia growth is driven by screen time and aging populations, while astigmatism benefits from advanced topography systems, such as the Cassini topographer, providing accurate corneal maps.
By End-User: Hospitals lead due to higher procedural volumes and access to advanced equipment, while ophthalmic clinics are projected to grow at the highest CAGR due to increasing availability of diagnostic solutions. Telehealth and academic clinics are emerging as significant contributors through strategic partnerships, such as Visionix and 20/20NOW in 2023, expanding tele-optometry services.
Competitive Landscape
The market is consolidated with Carl Zeiss Meditech AG, Topcon Corporation, and Alcon Inc. holding the majority share. Companies focus on strategic alliances, acquisitions, and new product launches to expand their global presence. Other key players include NIDEK, Haag-Streit Group, EssilorLuxottica, Rexxam, Schwind eye-tech, and Mediworks. Notable developments include EssilorLuxottica acquiring 80% of Heidelberg Engineering in 2024 and Haag-Streit Japan K.K. launch in 2023.
Market Trends
Technological advancements are transforming the market, including dynamic wavefront aberrometry, multimodal topography, and portable devices for remote eye care. AI and IoT integration enhance diagnostic precision, workflow efficiency, and personalized patient care.
COVID-19 Impact
The pandemic caused a temporary decline in demand due to reduced patient visits and supply chain disruptions. Carl Zeiss Meditech AG reported a -7% sales decline in 2020. Post-2021, market recovery has been observed as patient visits increased.
Conclusion
The global aberrometer & topography systems market is poised for substantial growth from USD 501.24 million in 2025 to USD 836.73 million by 2034, driven by technological innovations, increasing prevalence of eye disorders, and strategic initiatives by market leaders. Despite challenges such as high device costs and skilled workforce shortages, the market presents significant opportunities across all regions, particularly in Asia Pacific, telehealth, and advanced diagnostic solutions.
Segmentation By Type
By Indication
By End-user
By Geography